A Trial of Rosiglitazone for Ulcerative Colitis

NCT00065065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis
Inflammatory Bowel Disease

Interventions

DRUG: Rosiglitazone
DRUG: Placebo

Sponsor

James Lewis

Collaborators

[object Object]
[object Object]